First patient in EORTC's trial for retroperitoneal sarcoma

Study in pancreatic cancer improved survival rate of mice

A publication by scientists of the Anticancer Fund

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

Christoffer Gebhardt, Sonja C S Simon, Rebekka Weber, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, Jochen Utikal. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology, 2021 Feb;360:104274, doi: 10.1016/j.cellimm.2020.104274

The MATAO trial for ovarian cancer patients is open for participation

Discovering Darwin in oncology: Launch of a ‘Request for Application’ for researchers in evolutionary therapy

Finding existing drugs potentially active against BRCA mutated breast cancers: a literature based approach

Presented on EBCC-12, the 12th European Breast Cancer Conference
A publication by scientists of the Anticancer Fund

Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice

Benson Chellakkan Selvanesan, Kiran Meena, Amanda Beck, Lydie Meheus, Olaya Lara, Ilse Rooman, Claudia Gravekamp. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice. Journal for Immunotherapy for Cancer, 2020;8:e001250, doi:10.1136/jitc-2020-001250

ReDIReCT - Repurposing of Drugs: Innovative Revision of Cancer Treatment

ReDIReCT - Repurposing of Drugs: Innovative Revision of Cancer Treatment, Ciska Verbaanderd, PhD